Posted inBiotechnology
High-Resolution Distributed Brillouin Sensing via Transient Waves
In a groundbreaking advancement poised to reshape the landscape of optical sensing technologies, researchers led by Zhou, Y., Cheng, Y.,…
Posted inBiotechnology
Psilocybin Enters Gastroenterology: Pioneering Psychedelic Trial Targets Treatment-Resistant IBS
In a groundbreaking leap for psychedelic medicine and gastroenterology, Dr. Erin E. Mauney, an assistant professor of pediatrics at Tufts…
Posted inBiotechnology
Wendelstein 7-X Achieves Breakthrough Performance Milestone in Nuclear Fusion Research
Wendelstein 7-X Stellarator Sets New World Record in Sustained Fusion Plasma Performance At the forefront of fusion energy research, stellarators…
Posted inBiotechnology
How Speech Technology is Revolutionizing Clinical Research
ATLANTA, Georgia, USA, June 3, 2025 — In a groundbreaking interview published today in the peer-reviewed journal Psychedelics, Dr. Deanna…
Posted inBiotechnology
Infant Brain Connectivity at 3 Months Forecasts Emotional Development
A groundbreaking new study from the University of Pittsburgh School of Medicine sheds light on the earliest neural underpinnings of…
Posted inBiotechnology
Spending Time in Nature Eases Chronic Back Pain, Study Finds
Spending time amidst natural environments offers a promising avenue for individuals enduring chronic lower back pain to find relief and…
Posted inBiotechnology
African Swine Fever Endemic in Europe: No Recent Imports Confirmed
The African Swine Fever Virus (ASFV), a highly contagious and devastating pathogen, has long been a formidable threat to global…
Posted inBiotechnology
Biosensors Revolutionize Gastrointestinal Tumor Detection
In the relentless pursuit of advancing medical diagnostics, biosensor technology has emerged as a beacon of hope, particularly in the…
Posted inGenetics
Diminished Stress Response in Aging Neurons Linked to Neurodegeneration
As people age, their risk of developing neurodegenerative disorders like dementia, Alzheimer’s disease, and Parkinson’s disease increases. A new study…
Posted inGenetics
Kymera’s STAT6 Degrader for Inflammatory Disease Shows Early Success in Phase I
Kymera Therapeutics has announced positive results in an early-stage Phase I trial for an investigational drug designed to treat millions…